Sensex Today | Share Market Live Updates: Sensex sheds 200 pts; ITC, HUL drag;

Amid the ongoing geopolitical crisis and global headwinds, Reserve Bank of India Governor Shaktkandta Das, on Friday, said interest rates will remain high at the moment. Moreover, he refrained from telling for how long interest rates will remain at elevated level.

“Interest rate will remain high at the moment, (for) how long, only time will tell,” the governor said in response to a query at Kautilya Economic Conclave 2023 on Friday. (Read More)

Bombay Burmah Trading Corp share price witnessed a massive surge to hit a 52-week high on Friday. Bombay Burmah Trading shares were locked at 20% upper circuit at ₹1,420.50 apiece on the BSE, which is also its 52-week high price.

Around 1.98 lakh shares of Bombay Burmah Trading Corp changed hands today on BSE. The figure was way more than the two-week average volume of 3,959 shares, according to a Business Today report. Turnover on the counter stood at ₹27.51 crore. (Read More)

Sigachi Industries shares demonstrated an upward trend since the early morning transactions. The share price opened at ₹39.30 per share on the NSE, with an upward gap, and subsequently reached an intraday high of ₹43.85 per share, marking a new 52-week high for the company.

According to the recent exchange filing by the pharmaceutical company, Sigachi Industries Ltd has entered into an agreement with Saudi National Projects Investment Ltd (SNP) to establish a joint venture, Sigachi Arabia. This strategic move is intended to facilitate the company’s entry into the swiftly expanding Saudi Arabian market. (Read More)

TVS Motor Company, a leading manufacturer of two-wheelers and three-wheelers globally, announced its momentous entry into the Venezuelan market today.

“This makes TVS Motor the first Indian automobile manufacturer to enter the market with a host of 14 SKUs for the enthusiastic riders of Venezuela, with their local distributor, SERVISUMINISTROS JPG,” the company said in today’s regulatory filing. (Read More)

India’s Glenmark Life Sciences reported an 11.1% rise in second-quarter profit on Friday, led by strong growth in its mainstay active pharmaceutical ingredients (API) business in domestic as well as U.S. and European markets.

The Mumbai-based drugmaker said its profit rose to 1.19 billion rupees ($14.3 million) for the quarter ended Sept. 30, from 1.07 billion rupees a year earlier.

The company, spun off from Glenmark Pharmaceuticals in 2019 to focus on the API business, said its revenue from operations jumped nearly 17% to 5.95 billion rupees, with regulated markets including the U.S., Europe, Latin America and India contributing 80%. (Reuters)

HFCL’s sustains a steady growth trajectory on the back of its diverse offerings, strong order book and international expansion

• Order book stands at INR7078 crores, up from INR 5280 crores in Q2FY23

• Revenue in Q2FY24 stands at INR1111.49 crores as againstINR1173.47 crores inQ2FY23

• EBIDTA margin stands at 13.47 % inQ2FY24 as compared to 14.88 % inQ2FY23

• PBT margin stands at 8.47 % inQ2FY24 as compared to 9.70% in Q2FY23

• PAT margin stands at 6.31 % in Q2FY24 compared to 7.18 % in Q2FY23

JSW Holdings Limited, a Non-Banking Financial Company (NBFC), has officially notified the Bombay Stock Exchange (BSE) regarding its upcoming Board of Directors meeting scheduled for October 31. The…